Company intelligence / Profile preview

Sopharma

Sofia, Sofia-Capital, Bulgariasopharmagroup.com ↗
Ownership
Private
Employees
~6099
Development stage
Other
01

Overview

Sopharma is Bulgaria’s largest pharmaceutical producer, with a portfolio of over 200 products—mainly generics but also original phyto-based medicines. Its best-known original brands include Tabex, Carsil, and Tempalgin. The company operates multiple GMP-compliant manufacturing facilities in Bulgaria, Ukraine, and Serbia. It has a strong export business focused on Russia/CIS countries as well as the EU. Clinical results for individual programs are not typically published due to the generic nature of most products.

Therapeutic areas
NeurologyWomen's HealthPulmonologyGastroenterologyImmunologyCardiovascular
Modalities
Small moleculePhytopharmaceutical (plant-based drugs)Biologic (limited; focus is on generics and phyto-based products)
Industry
Biotech
02

Drug pipeline

1 asset

Tribestan

Unknown
03

Partnerships

Not specifically disclosed; distribution partnerships across Europe/Russia/CIS noted.

Beyond the preview

Go deeper on Sopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sopharma.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call